We conducted a 10-year retrospective study to determine the prognosis of necrotizing cervical fasciitis (NCF). Our study population included 38 patients-32 males and 6 females, aged 10 months to 70 years (mean: 55 yr)-who had presented for management of NCF at our tertiary care hospital between Jan. 1, 2000, and Dec. 31, 2009. We classified each case into four categories based on the duration of disease prior to presentation, the severity of disease, and other factors that influence outcomes. We found that the most important factor in determining prognosis was the time interval between the onset of NCF and subsequent presentation for specialist or surgical intervention. Patients with a higher grade of NCF had longer hospital stays. Although aggressive surgical and medical intervention is the gold standard for the management of NCF, many of our patients presented with a relatively healthy appearing wound, which could mislead the evaluating clinician and delay prompt management. We believe that our new grading system will help obviate this problem and make clinicians more vigilant when faced with a new case of necrotizing fasciitis.
Introduction
Necrotizing fasciitis is a rapidly spreading gangrene of subcutaneous tissue and deep fascia that tends to undermine the skin. Skin and muscle tissue remain intact until late in the course of the disease. Necrotizing fasciitis can involve any part of the body. If not controlled promptly, it can cause severe morbidity and even death. Necrotizing cervical fasciitis (NCF) is a particularly serious form of this dreaded condition, as fatal complications can occur within a few hours of its onset. Worldwide, the standard management protocol for NCF is aggressive surgical debridement with critical care.
Numerous factors can influence the outcome of patients with NCF, [1] [2] [3] [4] [5] [6] [7] and therefore the prognosis cannot be reliably predicted for any given patient. In an attempt to alleviate some of this uncertainty, we conducted a study of NCF cases managed at our institution. Our goal was to identify presenting clinical characteristics and classify them as a means to determine a prognosis for individual patients.
Patients and methods
We retrospectively reviewed our hospital's admission records covering the period from Jan. 1, 2000 1, , through Dec. 31, 2009 , to identify cases of NCF that would be suitable for our study. Our inclusion criteria stipulated that we would consider only cases of necrotizing fasciitis that had originated in the neck; cases that had arisen from the face and head were excluded.
A total of 38 patients met our eligibility criteria. The study population included 32 males and 6 females, aged 10 months to 70 years (mean: 55 yr). In addition to demographic data, we collected information on the amount of time that had passed between the onset of NCF and presentation for medical care and the presence of any coexisting disease. The study protocol was approved by the Institutional Review Board of the Indira Gandhi Medical College (IGMC).
On the basis of the clinical sequence of necrotizing fasciitis (figure 1), we classified it into four grades and named it the IGMC grading system: ENT-Ear, Nose & Throat Journal  March 2013 Grade I. The interval between the onset of signs and symptoms and the first surgical intervention is 3 days or less. Patients with erythema or other skin discoloration except for black discoloration and fluctuation are included in this grade. In our study, 2 patients had grade I NCF, including the youngest patient, a 10-month-old girl.
Grade II. The interval between the onset of signs and symptoms and the first surgical intervention is 4 through 7 days. This grade is characterized by black skin, crepitus, exposed dermis, and platysma. Half of our patients (n = 19) presented with grade II NCF.
Grade III. The interval between onset and intervention is 8 days or more. Criteria include a loss of sensation and exposure of the deep fascia, muscle, and blood vessels. There were 9 cases of grade III NCF in our study (figure 2, A).
Grade IV. This grade is characterized by the presence of any of the aforementioned signs and symptoms plus septicemia, shock, or involvement of the thorax. Our study included 8 patients with grade IV NCF. Of these, 4 were in shock, 2 exhibited chest skin necrosis, and 2 who had grade II signs and symptoms at the time of admission were later found to have thoracic extension.
Results
The major predisposing factor in the onset of disease in our study was dental infection, which progressed to NCF in 36 patients (94.7%). In 1 patient, the inciting mechanism was an infection of a hair follicle on the cheek, and in another case, a tonsillar infection was the root cause. All 38 patients reported neck pain as their major symptom.
Upon admission, all patients were administered hemodynamic and respiratory support. Patients were started on intravenous antibiotics, including amoxicillin/clavulanate, metronidazole, and gentamicin; the regimen was later adjusted according to pus culture and sensitivity results. The 4 patients who were in shock were also put on a dopamine drip. All patients were taken to the operating room for wound exploration, toileting, and debridement as necessary. Twelve patients had no necrotic tissue, and they underwent toileting only.
Findings and outcomes according to IGMC grade are summarized in the table:
Grade I. The 2 patients with grade I NCF were a 10-month-old girl and a 58-year-old woman. Both had presented for expert consultation 3 days after the onset of signs and symptoms. As a result of early intervention, these patients required less hospital time (mean: 12 days) than did the others in this study. Both of these patients had a single pathogen (group A streptococci), and they were managed with primary closure by releasing the adjoining skin.
Grade II. The 19 patients with grade II NCF were made up of 17 men and 2 women, aged 32 to 70 years (mean: 55; median: 58). The mean hospital stay was 26 days. These patients harbored various types of bacterial growth; the primary pathogens were gram-positive and gram-negative aerobes and anaerobes. All patients underwent split-thickness skin grafting. The skin grafts caused minimal skin contraction that resolved fully with physiotherapy within 1 year.
Grade III. Nine patients-8 men and 1 woman, aged 28 to 67 years (mean: 54; median: 57)-presented with grade III NCF. Their mean hospital stay (52 days) was twice as long as that of the patients with grade II disease. The types of bacterial growth in this group were similar to those of the grade II group, and the type of reconstructive surgery was the same (figure 2, B) .
Grade IV. The 8 patients with grade IV NCF included 7 men and 1 woman, aged 41 to 70 years (mean: 62; median: 66). Their bacteria were mixed. All 4 patients in shock were diabetic, and 2 of them died within 8 days. All of the 6 surviving patients (including 2 other diabetics) had empyema, and they were treated with split-thickness >7 days:
Loss of sensation (ominous sign)
Toxic shock syndrome leading to severe necrosis, hypotensive shock, or multiorgan failure
Triggering infection skin grafting and intercostal drainage. Including the 2 patients who died, the mean hospital stay was 38 days; without them, the mean stay was 54 days.
Discussion
Historical documentation of necrotizing fasciitis dates back to the time of Hippocrates in the 5th century B.C. 8 The actual term was coined in 1952 by Wilson. 9 The root causes of NCF include dental infection (~80% of cases), trauma, boils, peritonsillar abscess, pharyngitis, insect bites, surgery, and varicella. Necrotizing fasciitis of the head and neck usually occurs in elderly patients; there are a few reports in children. [16] [17] [18] [19] [20] The disease predominantly affects males, although some studies have shown a female preponderance, especially among patients older than 60 years. 6, 16 The male-tofemale ratio in our study was 5.5:1.
Once the onset of necrotizing fasciitis is triggered (e.g., by a dental infection), a dark-red area of ulceration will arise 36 to 72 hours later ( figure 1) . The lesion will feature three distinct zones: (1) a central zone of necrosis surrounded by (2) a dusky tender zone and (3) a wide peripheral zone of erythema. By 3 or 4 days later, the patient will develop cutaneous bullae and surgical emphysema (with H 2 , N 2 , NO, and H 2 S gases). One week after onset or later, the patient will develop a loss of sensation in the involved area, which is an ominous sign. Next, toxic shock syndrome will develop, which will lead to either severe tissue necrosis, hypotensive shock, or multiorgan failure.
It is well established that patients with necrotizing fasciitis should be taken to the operating room for immediate wound exploration and aggressive debridement of necrotic tissue. (Necrotic tissue was present in 26 of the 38 patients in our study.) When treatment is delayed, mortality from NCF ranges from 25 to 78%. [1] [2] [3] [4] [5] [6] [7] Initially, patients are infused with a penicillin (amoxicillin/clavulanate), metronidazole, and an aminoglyco- Figure 2 . A: Clinical photograph shows a patient with grade III NCF. B: Following treatment and the placement of a split-thickness skin graft, the wound is fully healed.
B A side. The antibiotic regimen is adjusted once the culture and bacterial sensitivity report becomes available. Hyperbaric oxygen therapy has been found to shorten hospital stays for patients with NCF. 25 Hyperbaric oxygen was not administered to the patients in this study because this method of treatment was not available at our hospital.
It has been well established that NCF progresses over time. Therefore, the interval between onset and intervention is the most important prognostic factor. In a similar study conducted in our area of India, Panda et al also found that treatment delays affected the prognosis. 6 Wong et al 26 have suggested laboratory risk indicators to differentiate non-necrotizing from necrotizing fasciitis. However, their scale has limited clinical importance, and sometimes it can be deceptive. [27] [28] [29] [30] Because clinical suspicion is still important, we also incorporated a time factor into our IGMC grading system so that clinicians might not be misled by the degree of signs and symptoms of NCF if, for example, the patient were to present with only a healthy-appearing wound, as did some of ours.
It has also been reported that comorbid conditions and immunodeficiency states can worsen the prognosis. 6 We were unable to ascertain any such direct relationship in our study, but it is noteworthy that diabetes was associated with septic shock and subsequent death in 2 cases.
The major limitation of our study was its small sample size, so our results should be interpreted with caution. For example, the presence of a single type of bacteria in grade I NCF cannot be considered significant since there were only 2 such cases. Therefore, further research with larger samples is needed to refine the exact clinical profile and prognosis associated with each grade. Until then, we hope this new IGMC grading system will help physicians better assess necrotizing fasciitis by their not relying solely on obvious clinical signs.
